Scientist Who Pioneered 'Three-Parent' IVF Embryo Technique Now Wants to Offer it to Older Women Trying For a Baby
By Steve Connor,
The Independent
| 02. 08. 2015
Untitled Document
Older women trying for a baby could soon be offered the IVF technique of so-called “three-parent” embryos that would help families with serious mitochondrial diseases to have healthy children, and which won the backing of MPs last week.
The US scientist who pioneered the technique of mitochondrial transfer has applied for permission to use it as a fertility treatment for women who, because of their age, have difficulty becoming pregnant naturally or by conventional IVF.
Dr Shoukhrat Mitalipov, a world authority on embryo manipulation, said he had requested permission from the US Food and Drug Administration (FDA) to conduct trials of mitochondrial transfer as a treatment for age-related infertility. He said the parliamentary vote last Tuesday, when MPs overwhelmingly approved the “three-parent” baby technique for creating IVF babies free of mitochondrial disease, has bolstered his case with the US regulator.
“We hope it will help in the US, and hopefully the FDA will move faster. The families have heard about the UK outcome and they welcome it. We’re very excited by it,” said Dr Mitalipov, senior scientist at...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...